Editorial Comment from Dr Chapple to Long-term safety and efficacy of the novel β3 -adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study

Int J Urol. 2018 Jul;25(7):677. doi: 10.1111/iju.13715. Epub 2018 Jun 4.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adrenergic beta-3 Receptor Agonists*
  • Humans
  • Prospective Studies
  • Pyrimidinones
  • Pyrrolidines
  • Urinary Bladder, Overactive*

Substances

  • Adrenergic beta-3 Receptor Agonists
  • N-(4-((5-(hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo(1,2-a)pyrimidine-6-carboxamide
  • Pyrimidinones
  • Pyrrolidines